Innovative Treatment eNeura specializes in portable, at-home migraine treatment devices utilizing single-pulse Transcranial Magnetic Stimulation (sTMS), creating opportunities to target neurology clinics, headache specialists, and outpatient care centers seeking advanced, patient-friendly solutions.

Recent Leadership Change The appointment of a new CEO in February 2020 indicates a potential shift in corporate strategy and growth focus, making outreach to executive leadership beneficial for partnership and expansion opportunities.

Strategic Relocation Moving manufacturing and customer service operations from California suggests opportunities to engage with new logistical partners and explore regional expansion or local service enhancements.

Funding & Growth With $11 million in debt financing and a revenue range of up to 1 million dollars, eNeura is positioned for targeted growth, particularly in neurology device markets, presenting opportunities for sale of complementary equipment or service solutions.

Market Potential Operating in the specialized medical device sector with FDA-cleared products and partnerships with headache specialists, eNeura offers a pathway to expand product offerings, clinical partnerships, and integration with healthcare providers focused on migraine management.